There are still lots of open positions. Let's find the one that's right for you.
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Senior Director, Epidemiology is responsible for leading the strategy and execution of epidemiology plans and activities related to all Revolution medicines assets. They will be accountable to working across the development, safety, medical affairs and commercial matrix to understand the needs and deliver evidence aligned to the critical priorities of Revmed products. Reporting to the VP, HEOR and RWE the Dir, Epidemiology will sit on their leadership team and provide input into the broader remit of the group. They will also closely align with the Safety organization to facilitate the proper evaluation of benefit/risk of Revmed products. This is an exceptional opportunity to contribute to the advancement of healthcare by providing evidence that can shape the future of patient care in Oncology.